To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.

Completed · Phase 3

Conditions studied: Alzheimer's Disease

In brief

The purpose of this study is to find out if atovastatin, when taken with a cholinesterase inhibitor, is effective for treating Alzheimer's disease.

Key facts

Study ID

NCT00151502

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

600

Starts

2002-11-01

Expected to finish

2007-07-01

Last updated by the study team

2021-02-18

Who can join

Age: 50 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnostic evidence of probable Alzheimer's disease consistent with NINCDS/ADRDA and DSM IV criteria.
• Subject's Mini-Mental Status Examination Score (MMSE) must be in the range of 13 - 25 (inclusive) at Screening.

You may not qualify if…

• Subjects with dementia due to causes other than Alzheimer's disease.
• Any condition, which, in the investigator's judgment might increase the risk to the subject or decrease the reliability of the data required to meet the objectives of the study.

Where it is running

• Pfizer Investigational Site — Fresno, California, United States
• Pfizer Investigational Site — Laguna Hills, California, United States
• Pfizer Investigational Site — San Francisco, California, United States
• Pfizer Investigational Site — Fort Lauderdale, Florida, United States
• Pfizer Investigational Site — Fort Myers, Florida, United States
• Pfizer Investigational Site — Miami Beach, Florida, United States
• Pfizer Investigational Site — Pompano Beach, Florida, United States
• Pfizer Investigational Site — St. Petersburg, Florida, United States
• Pfizer Investigational Site — West Palm Beach, Florida, United States
• Pfizer Investigational Site — Fort Wayne, Indiana, United States
• Pfizer Investigational Site — Paducah, Kentucky, United States
• Pfizer Investigational Site — New Orleans, Louisiana, United States
• Pfizer Investigational Site — South Dartmouth, Massachusetts, United States
• Pfizer Investigational Site — West Yarmouth, Massachusetts, United States
• Pfizer Investigational Site — Worcester, Massachusetts, United States
• Pfizer Investigational Site — Kalamazoo, Michigan, United States
• Pfizer Investigational Site — Jamesburg, New Jersey, United States
• Pfizer Investigational Site — Princeton, New Jersey, United States
• Pfizer Investigational Site — Albuquerque, New Mexico, United States
• Pfizer Investigational Site — Albany, New York, United States
• Pfizer Investigational Site — Rochester, New York, United States
• Pfizer Investigational Site — Troy, New York, United States
• Pfizer Investigational Site — Tulsa, Oklahoma, United States
• Pfizer Investigational Site — Allentown, Pennsylvania, United States
• Pfizer Investigational Site — Sun City, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.